Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Inspire Medical Systems (INSP) EBIAT (2017 - 2025)

Inspire Medical Systems' EBIAT history spans 9 years, with the latest figure at $136.1 million for Q4 2025.

  • For Q4 2025, EBIAT rose 286.36% year-over-year to $136.1 million; the TTM value through Dec 2025 reached $145.4 million, up 171.77%, while the annual FY2025 figure was $145.4 million, 171.77% up from the prior year.
  • EBIAT for Q4 2025 was $136.1 million at Inspire Medical Systems, up from $9.9 million in the prior quarter.
  • Across five years, EBIAT topped out at $136.1 million in Q4 2025 and bottomed at -$16.8 million in Q3 2022.
  • The 5-year median for EBIAT is -$6.1 million (2023), against an average of $4.5 million.
  • The largest annual shift saw EBIAT skyrocketed 368.67% in 2023 before it crashed 136.68% in 2025.
  • A 5-year view of EBIAT shows it stood at -$2.4 million in 2021, then skyrocketed by 231.74% to $3.2 million in 2022, then surged by 368.67% to $14.8 million in 2023, then surged by 138.6% to $35.2 million in 2024, then soared by 286.36% to $136.1 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's EBIAT are $136.1 million (Q4 2025), $9.9 million (Q3 2025), and -$3.6 million (Q2 2025).